Loading clinical trials...
Loading clinical trials...
The purposes of this study are to evaluate the safety of 13-valent pneumococcal Conjugate Vaccine (13vPnC) in children who have already been vaccinated with Prevenar. The study will also assess the im...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06000397 · Pneumococcal Vaccines, Immunization Coverage
NCT07365826 · Pneumococcal Vaccines
NCT06703203 · Pneumococcal Vaccines
NCT03893448 · Pneumococcal Infections, Pneumococcal Vaccines
NCT02012309 · HIV, Pneumococcal Infections, and more
Pfizer Investigational Site
Eskilstuna
Pfizer Investigational Site
Gothenburg
Pfizer Investigational Site
Malmo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions